Veridex, LLC, a subsidiary of Johnson & Johnson, will acquire Immunicon for $31 million in cash. Immunicon filed for bankruptcy on Wednesday; the announcement sent shares tumbling to from $.27 to $.09. […]
Hologic Gets Heptatis C, HPV with Third Wave Acquisition
Hologic, an established provider of diagnostic products and therapeutic devices, will acquire Third Wave Technologies in a $580 million deal. Third Wave develops molecular diagnostic reagents for a wide variety of DNA […]
[Video Profile] Interview with Bob Mills, President of Envisioneering Medical
Prostate cancer is the second leading cause of cancer death in men. The cancer stems from a malignant tumor that originates in the prostate gland. As the tumor grows it can spread […]
[Quick Take] Interview with Broughan Gorey, CEO of Concierge MedTravel
As the name implies, Concierge MedTravel is a medical travel service. Concierge arranges appointments, international travel, transportation, hotel and hospital accommodations for clients. The company caters to men in need of a […]
Aethlon Medical: Time to Focus
You’ve got to hand it to the PR folks at Aethlon Medical. Every time I come across one of the company’s press releases I think I’ve stumbled upon the holy grail of […]
Upgraded Enlarged Prostate Treatment Catheter from Urologix: CTC Advance
This week, the OneMedPlace team is down in Orlando attending the American Urological Association’s annual meeting. We’ll be capturing some great video footage from the floor which we’ll be sharing later this […]
[Video Profile] Interview with James Datin, Executive VP and Managing Director of Safeguard Scientifics
Safeguard Scientifics is a holding company that invests in growth-stage life sciences and technology. In addition to capital, Safeguard provides strategic, operational and management resources to its portfolio companies. As a public […]
Myriad Goes Direct (Again)
Myriad Genetic Laboratories develops and markets proprietary predictive and personalized medicine products. This includes the poorly branded BRACAnalysis, to assess a woman’s risk of developing breast or ovarian cancer based on detection […]
